Intracranial hypertension syndrome in systemic lupus erythematosus: Clinical analysis and review of the literature

  title={Intracranial hypertension syndrome in systemic lupus erythematosus: Clinical analysis and review of the literature},
  author={Zheng Xue and Xue-zhen Wang and Fei Liu and Shaoxian Hu and Suiqiang Zhu and Su-ming Zhang and Bitao Bu},
  journal={Journal of Huazhong University of Science and Technology [Medical Sciences]},
  • Z. Xue, Xue-zhen Wang, B. Bu
  • Published 18 February 2009
  • Medicine
  • Journal of Huazhong University of Science and Technology [Medical Sciences]
SummaryIn order to better understand the clinical manifestation of systemic lupus erythematosus (SLE) with intracranial hypertension syndrome (IHS), we analyzed the clinical features and treatment of a typical SLE patient with IHS. SLE is one of the most unpredictable autoimmune diseases involving multiple organ systems that is defined clinically and associated with antibodies directed against cell nuclei. IHS is an uncommon manifestation of neuropsychiatric SLE (NPSLE) and is characterized by… 

Malignant cerebral edema related to Systemic Lupus Erythematosus

Prevalence, outcome and prognostic factors of neuropsychiatric systemic lupus erythematosus: A real world single center study

An 11.14-fold increased mortality of NPSLE patients compared with general population is demonstrated and acute confusional state is the most significant predictive factor for poor prognosis.

Systemic Lupus Erythematosus: A Review

Basic fundamentals of systemic lupus erythematosus are dealt with, the epidemiology, the pathology of the disease, the sign and symptoms of the Disease, the current therapy available and scope of research in this field.



Systemic lupus erythematosus presenting with pseudotumor cerebri: a rare association.

It is suggested that pulse steroids and azathioprine is an effective treatment for this feature of systemic lupus erythematous SLE and should be considered in the differential diagnosis.

[A case of benign intracranial hypertension associated with systemic lupus erythematosus (SLE) showing diffuse white matter lesions on MRI].

We describe a 35-year-old woman with benign intracranial hypertension (BIH) secondary to systemic lupus erythematosus (SLE). She had low grade fever and skin eruptions, but neurological examination

Headache in systemic lupus erythematosus and its relation to other disease manifestations.

Headache is common in SLE, and in the majority of patients is related to musculoskeletal and constitutional disease manifestations, and the total arthritis score, muscle pain, fatigue and photosensitivity were each found to be significantly independently related to headache.

A neuroimaging follow up study of a patient with juvenile central nervous system systemic lupus erythematosus

The anatomical substrate, metabolic aspect, neuroimaging, and clinical course of MS-like lesions in a child with CNS-SLE are described and the way in which radiological techniques can support clinical decision making in this young patient with progressive CNS-Lupus erythematosus is illustrated.

Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients

Multifactor analysis revealed that high SLICC/ACR-DI scores and sets of concurrent NP symptoms were independently associated with poor outcome, whereas pulse IVMP and IT injection of MTX plus DXM were protective factors against poor outcome.

Recent advances and future perspective in neuroimaging in neuropsychiatric systemic lupus erythematosus

New functional techniques such as magnetic resonance spectroscopy, diffusion and perfusion weighted imaging, and magnetization transfer imaging may be useful in order to indentify pathologic changes unrevealed by conventional imaging.

Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations

Brain imaging by MRI and SPECT applied to SLE patients appears to express CNS involvement significantly related to specific categories of NP manifestations, and neuropsychiatric manifestations, namely those of the organic/major type, appeared to be significantly associated to the presence of a serum antibody against GFAP, a gliotypic antigen.

Psychiatric manifestations in systemic lupus erythematosus.

Central nervous system lupus: a clinical approach to therapy

The use of intrathecalmethotrexateand dexamethasone has been reported in a small series of patients, with a good outcome in patients with severe CNS manifestations, and anticoagulation is warranted in Patients with thrombotic disease.

Optimizing clinical monitoring of central nervous system involvement in SLE.